BALJIT SINGH: Open Payments
NPI 1487045837 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,477 in 18 payments from 8 companies in 2025. Trend: 2023 $213 · 2024 $833 · 2025 $1,477
Food & beverage: $1,477
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $350 |
| Collegium Pharmaceutical, Inc. | 2 | $250 |
| Teva Pharmaceuticals USA, Inc. | 2 | $233 |
| E.R. Squibb & Sons, L.L.C. | 5 | $168 |
| Otsuka America Pharmaceutical, Inc. | 2 | $147 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $121 |
| Janssen Pharmaceuticals, Inc | 2 | $82 |
Products named: Jornay PM, LYBALVI, AUSTEDO XR, COBENFY, FANAPT, ABILIFY MAINTENA, QUVIVIQ, ARISTADA.
Industry payments across MI — which companies pay providers there.
